@article{3086925,
    title = "BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era",
    author = "Papageorgiou, S.G. and Kontos, C.K. and Foukas, P.G. and Panopoulou, E. and Vasilatou, D. and Rapti, S.-M. and Gkontopoulos, K. and Bazani, E. and Panayiotides, I.G. and Dimitriadis, G. and Scorilas, A. and Pappa, V.",
    journal = "Clinical Lymphoma Myeloma and Leukemia",
    year = "2016",
    volume = "57",
    number = "9",
    pages = "2199-2203",
    publisher = "Taylor and Francis Ltd.",
    doi = "10.3109/10428194.2015.1126588",
    keywords = "BCL2L12 protein;  common acute lymphoblastic leukemia antigen;  cyclophosphamide;  doxorubicin;  interferon regulatory factor 4;  Ki 67 antigen;  messenger RNA;  mitoxantrone;  prednisone;  protein bcl 2;  protein bcl 6;  protein p53;  rituximab;  tumor marker;  unclassified drug;  vincristine;  antineoplastic agent;  BCL2L12 protein, human;  muscle protein;  pharmacological biomarker;  protein bcl 2;  rituximab;  tumor marker, apoptosis;  B lymphocyte;  B lymphocyte differentiation;  cancer combination chemotherapy;  cancer immunotherapy;  cancer survival;  chromosome 19q;  disease free survival;  follow up;  gene dosage;  gene locus;  genetic heterogeneity;  germinal center;  human;  immunohistochemistry;  International Prognostic Index;  large cell lymphoma;  Letter;  long term survival;  outcome assessment;  overall survival;  priority journal;  protein expression;  recurrence free survival;  survival rate;  treatment response;  diffuse large B cell lymphoma;  gene expression regulation;  genetics;  HL-60 cell line;  metabolism;  mortality;  prognosis;  survival analysis;  treatment outcome;  upregulation, Antineoplastic Combined Chemotherapy Protocols;  Biomarkers, Pharmacological;  Biomarkers, Tumor;  Gene Expression Regulation, Neoplastic;  HL-60 Cells;  Humans;  Lymphoma, Large B-Cell, Diffuse;  Muscle Proteins;  Prognosis;  Proto-Oncogene Proteins c-bcl-2;  Rituximab;  Survival Analysis;  Treatment Outcome;  Up-Regulation"
}